Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer

Despite the confirmed anti-cancer effects of T-cell immune checkpoint inhibitors, in colorectal cancer (CRC) they are only effective in a small subset of patients with microsatellite-unstable tumors. Thus, therapeutics targeting other types of CRCs or tumors refractory to T-cell checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimura-Nagata, Akane, Koshino, Akira, Inoue, Satoshi, Matsuo-Nagano, Aya, Komura, Masayuki, Riku, Miho, Ito, Hideaki, Inoko, Akihito, Murakami, Hideki, Ebi, Masahide, Ogasawara, Naotaka, Tsuzuki, Toyonori, Takahashi, Satoru, Kasugai, Kunio, Kasai, Kenji, Inaguma, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975978/
https://www.ncbi.nlm.nih.gov/pubmed/33799989
http://dx.doi.org/10.3390/ijms22052690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975978/
https://www.ncbi.nlm.nih.gov/pubmed/33799989
http://dx.doi.org/10.3390/ijms22052690

Ejemplares similares